SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-096228
Filing Date
2024-04-15
Accepted
2024-04-15 16:16:37
Documents
5
Effectiveness Date
2024-04-15

Document Format Files

Seq Description Document Type Size
1 S-8 d827268ds8.htm S-8 48574
2 EX-5.1 d827268dex51.htm EX-5.1 7152
3 EX-23.1 d827268dex231.htm EX-23.1 1541
4 EX-FILING FEES d827268dexfilingfees.htm EX-FILING FEES 14089
5 GRAPHIC g827268g0411230731745.jpg GRAPHIC 2533
  Complete submission text file 0001193125-24-096228.txt   76147
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-278686 | Film No.: 24844834
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)